Search Within

Karthik Nath

  1. "Hematologic Malignancies, Division of"
Formats
  1. Meeting Abstract (17)
  2. Journal Article (9)
  3. Review (3)
  4. Correspondence (1)
  5. Editorial (1)
Groups
  1. Center for Hematologic Malignancies (31)
  2. Department of Medicine (31)
  3. GME, Medicine (31)
  4. Graduate Medical Education (31)
  5. Hematologic Malignancies, Division of (31)
  6. Bone Marrow Transplant (27)

More Groups

People
  1. Gunjan Shah (22)
  2. Sergio Giralt (22)
  3. Michael Scordo (20)
  4. Sean Devlin (16)
  5. Sham Mailankody (15)
  6. Miguel-Angel Perales (14)

More People

Years
  1. 2025 (1)
  2. 2024 (7)
  3. 2023 (14)
  4. 2022 (9)
Publications
  1. Blood (9)
  2. Clinical Lymphoma, Myeloma and Leukemia (5)
  3. Bone Marrow Transplantation (3)
  4. Transplantation and Cellular Therapy (3)
  5. Blood Cancer Journal (2)
  6. American Journal of Hematology (1)

More Publications

Publishers
  1. American Society of Hematology (9)
  2. Elsevier Inc. (9)
  3. Nature Publishing Group (8)
  4. Ferrata Storti Foundation (1)
  5. Informa Healthcare (1)
  6. John Wiley & Sons, Inc. (1)

More Publishers

Results (31)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Predictors and implications of renal injury after CD19 chimeric antigen receptor T-cell therapy
    Journal Article

    Boardman, A. P.; Gutgarts, V.; Flynn, J. R.; Devlin, S. M.; Goldman, A.; Tomas, A. A.; Fein, J. A.; Slingerland, J. B.; Parascondola, A.; Lin, R. J.; more...
    Haematologica (2025)

    Fulltext@MSK | Save
  • Infectious complications during treatment with commercial CAR T-cell therapy and bispecific antibodies for relapsed/refractory multiple myeloma
    Meeting Abstract

    Jurgens, E. M.; Shekarkhand, T.; Farzana, T.; Rueda, C.; Nemirovsky, D.; Derkach, A.; Firestone, R. S.; Nishimura, N.; Miller, K.; Costa, B. A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Young matched unrelated donors should be prioritized over older-aged matched sibling donors and young haploidentical donors in allogeneic transplantation with post-transplant cyclophosphamide in recipients ≥ 50-years
    Meeting Abstract

    Nath, K.; Zhang, M. J.; Bye, M.; Lee, S.; Bolon, Y. T.; Benjamin, C.; Betts, B.; Gadalla, S.; Marsh, S. G. E.; Mehta, P.; more...
    Bone Marrow Transplantation (2024)

    Fulltext@MSK | Save
  • Superior disease control with younger matched unrelated donor vs older-aged matched sibling donor in recipients ≥ 50-years with ALL, AML, or MDS using CNI-based GVHD prophylaxis
    Meeting Abstract

    Nath, K.; Zhang, M. J.; Bye, M.; Lee, S.; Bolon, Y. T.; Benjamin, C.; Betts, B.; Gadalla, S.; Marsh, S. G. E.; Mehta, P.; more...
    Bone Marrow Transplantation (2024)

    Fulltext@MSK | Save
  • Incidence and clinical impact of acute kidney injury: A comparison of CAR T-cell and bispecific antibody therapies
    Meeting Abstract

    Nishimura, N.; Mailankody, S.; Nemirovsky, D.; Derkach, A.; Costa, B.; Farzana, T.; Jurgens, E.; Firestone, R.; Nath, K.; Chung, D.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Comparison of infectious complications with BCMA-directed therapies in multiple myeloma
    Journal Article

    Nath, K.; Shekarkhand, T.; Nemirovsky, D.; Derkach, A.; Costa, B. A.; Nishimura, N.; Farzana, T.; Rueda, C.; Chung, D. J.; Landau, H. J.; more...
    Blood Cancer Journal (2024)

    Fulltext@MSK | Save
  • Prognostic impact of corticosteroid and tocilizumab use following chimeric antigen receptor T-cell therapy for multiple myeloma
    Journal Article

    Costa, B. A.; Flynn, J.; Nishimura, N.; Devlin, S. M.; Farzana, T.; Rajeeve, S.; Chung, D. J.; Landau, H. J.; Lahoud, O. B.; Scordo, M.; more...
    Blood Cancer Journal (2024)

    Fulltext@MSK | Save
  • Reduced-intensity compared to nonmyeloablative conditioning in patients with non-Hodgkin lymphoma undergoing allogeneic hematopoietic stem cell transplantation
    Journal Article

    Nath, K.; Peterson, K.; Brown, S.; Devlin, S.; Rodriguez, N.; Barker, J.; Giralt, S.; Gyurkocza, B.; Jakubowski, A.; Papadopoulos, E.; more...
    Transplantation and Cellular Therapy (2024)

    Fulltext@MSK | Save
  • Comparison of bendamustine versus fludarabine/cyclophosphamide lymphodepletion in adult patients receiving CD19 CAR-T cell therapy
    Meeting Abstract

    Landego, I.; Nemirovsky, D.; Devlin, S. M.; Wills, B.; Parascondola, A.; Saldia, A.; Dahi, P. B.; Tomas, A. A.; Ip, A.; Suh, H. C.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • A phase II trial of prophylactic anakinra to prevent neurotoxicity in patients receiving anti-CD19 CAR T-cell therapy for relapsed or refractory lymphoma: Final results from cohort 2
    Meeting Abstract

    Nath, K.; Devlin, S. M.; Sauter, C. S.; Palomba, M. L.; Shah, G. L.; Dahi, P. B.; Lin, R. J.; Scordo, M.; Perales, M. A.; Leslie, L. A.; more...
    Blood (2023)

    Fulltext@MSK | Save